AidKit Wins “Best Use of Artificial Intelligence” at the 2025 Globee Awards for Impact
AidKit is recognized for transforming aid distribution through human-centered, responsible AI DENVER, Dec. 1, 2025 /PRNewswire/ — December 1, 2025 – AidKit,... Read more.
Pressure on the Humans Ecosystem in Uzbekistan Continues: Former UPay CEO Bekhzod Botirov Remains in Custody
Humans regard the arrest and continued detention of Bekhzod Botirov as the latest chapter in a broader pressure campaign against the company in connection with its... Read more.
AT&T to Release Fourth-Quarter 2025 Earnings on Jan. 28
DALLAS, Dec. 1, 2025 /PRNewswire/ — We will release our fourth-quarter 2025 results on Wednesday, Jan. 28, 2026, and webcast a conference call to discuss results.... Read more.
MaxsMaking Inc. Addresses SEC Trading Suspension and Affirms Full Cooperation with Regulators
SHANGHAI, Dec. 1, 2025 /PRNewswire/ — MaxsMaking Inc. (Nasdaq: MAMK) (“MaxsMaking” or the “Company”), a manufacturer of customized... Read more.
IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types
B7H3 and PTK7 is co-expressed in multiple solid tumor types, including lung, colorectal, and head and neck cancers, at approximately 30%, 46%, and 27%, respectively... Read more.
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current therapies... Read more.
Morphocell Technologies Completes US$50 Million Series A Financing
LAVAL, QC, Dec. 1, 2025 /PRNewswire/ – Morphocell Technologies Inc., a biotechnology company pioneering next-generation tissue therapeutics for organ replacement,... Read more.
Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study
Financing led by Novartis Venture Fund and Forbion, with new investment from Omega Funds, Droia Ventures, YK Bioventures, and Digitalis Ventures Renewed backing... Read more.
CerraCap Ventures and Impact Venture Capital Merge to Form CerraCap Impact Venture Capital, Creating a Global VC Platform Powered by the Industry’s Most Active Corporate Network
COSTA MESA, Calif., Dec. 1, 2025 /PRNewswire/ — CerraCap Ventures and Impact Venture Capital today announced their merger to form CerraCap Impact Venture Capital... Read more.
AutoShop Answers Announces the Appointment of Scott Thorley as Vice President of Sales Across Its Entire Family of Businesses
HOUSTON , Dec. 1, 2025 /PRNewswire/ — AutoShop Answers, a national leader in automotive business training performance systems, today announced that Scott... Read more.